Thank you very much.
We will now move on to Canada's Research-Based Pharmaceutical Companies (Rx&D). We have Mark Ferdinand, vice-president, policy, research, regulatory and scientific affairs.
The floor is yours for five minutes.
On November 29th, 2007. See this statement in context.